TLR7 and COVID-19: Later studies have additionally revealed novel, rare XL LOF variants in TLR7 in young males critically ill with COVID-19, with these defects being shown to underlie severe COVID-19 disease in 1–2% of men under 60 years of age [26,27,28,29].